Biosenic (CHIX:BIOSB) Other Stockholders Equity: €-0.07 Mil (As of Dec. 2024)


CHIX:BIOSB Biosenic CHIX:BIOSB
9 GF Score
Price €2.60
View Full Analysis

What is Biosenic Other Stockholders Equity?

Biosenic CHIX:BIOSB 9 Other Stockholders Equity is €-0.07 Mil as of Dec. 2024. GuruFocus rates CHIX:BIOSB with a GF Score™ of 9/100.

Biosenic's Other Stockholders Equity for the quarter that ended in Dec. 2024 was €-0.07 Mil.

Biosenic's quarterly Other Stockholders Equity declined from Dec. 2023 (€-0.02 Mil) to Jun. 2024 (€-0.08 Mil) but then increased from Jun. 2024 (€-0.08 Mil) to Dec. 2024 (€-0.07 Mil).

Biosenic's annual Other Stockholders Equity increased from Dec. 2022 (€-0.04 Mil) to Dec. 2023 (€-0.02 Mil) but then declined from Dec. 2023 (€-0.02 Mil) to Dec. 2024 (€-0.07 Mil).

Biosenic Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Biosenic's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biosenic Other Stockholders Equity Chart

Biosenic Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.40 -0.08 -0.04 -0.02 -0.07

Biosenic Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -0.05 -0.02 -0.08 -0.07
CHIX:BIOSB
9GF Score
Biosenic CHIX:BIOSB
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biosenic Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €-0.07 Mil mean?
Biosenic (CHIX:BIOSB) has a Other Stockholders Equity of €-0.07 Mil as of Dec. 2024. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Biosenic and its competitors.
Is Biosenic's Other Stockholders Equity too high?
Biosenic's current Other Stockholders Equity is €-0.07 Mil. Overall, Biosenic has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Biosenic's Other Stockholders Equity compare to VRTX and REGN?
Biosenic's Other Stockholders Equity of €-0.07 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Biosenic and its competitors. Biosenic's current Other Stockholders Equity is €-0.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biosenic stock overvalued right now?
Biosenic (CHIX:BIOSB) has a current Other Stockholders Equity of €-0.07 Mil. The current Other Stockholders Equity is €-0.07 Mil. Biosenic's overall GF Score™ is 9/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Biosenic (CHIX:BIOSB), the current Other Stockholders Equity is €-0.07 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biosenic Business Description

Address Rue Granbonpre 11, Batiment H (bte 24), Mont-St-Guibert, BEL, 1435
Biosenic is engaged in the development of cell therapy products for orthopaedics and bone diseases. The product pipeline of the company includes; ALLOB for treatment of delayed-union fractures, spinal fusion procedures and revision spinal fusion, and PREOB. In addition, the firm is also focused on conducting preclinical research on next-generation product candidates such as combined cell-matrix products for large bone defects and maxillofacial applications.
9GF Score

Get the complete analysis for CHIX:BIOSB

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.60
Price